{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:41:15Z","timestamp":1750308075910,"version":"3.41.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,12]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Serotonin syndrome is a potentially life-threatening condition resulting from the use of antidepressants, their interactions with other serotonergic medications, or poisoning. It presents with a triad of psychiatric, dysautonomic, and neurological symptoms and is sometimes fatal. While cyproheptadine is a specific treatment option, the optimal duration of its administration remains unclear. The purpose of this report is to quantitatively assess the endpoints of serotonin syndrome treatment. Based on the hypothesis that neurological pupil index (NPi) on a digital pupil recorder would correlate with the severity of the serotonin syndrome, we administered cyproheptadine using NPi as an indicator.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A patient with a history of depression was brought to our hospital after he overdosed on 251 tablets of serotonin and noradrenaline reuptake inhibitors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>On day 3, the patient was diagnosed with serotonin syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Cyproheptadine syrup was administered at 4\u2009mg every 4 hours. The NPi of the automated pupillometer was simultaneously measured. On day 5, the NPi exceeded 3.0 cyproheptadine was discontinued.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient was discharged on day 7.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The lack of considerable improvement during the treatment period suggests that the patient may have improved on his own. In this case, the relationship between NPi and the severity of serotonin syndrome could not be determined.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037852","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T19:01:33Z","timestamp":1712948493000},"page":"e37852","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Serotonin syndrome treated with cyproheptadine using NPi from a digital pupillometer as a therapeutic indicator: A case report"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4465-5688","authenticated-orcid":false,"given":"Kazuki","family":"Sugaya","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Fukushima Medical University School of Medicine, Fukushima City, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomotaka","family":"Misawa","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Fukushima Medical University School of Medicine, Fukushima City, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Onodera","sequence":"additional","affiliation":[{"name":"Department of Regional Emergency Medicine, Fukushima Medical University, Fukushima City, Fukushima, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Iseki","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Fukushima Medical University School of Medicine, Fukushima City, Fukushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250618","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome.","volume":"352","author":"Boyer","year":"2005","journal-title":"N Engl J Med"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity.","volume":"96","author":"Dunkley","year":"2003","journal-title":"QJM"},{"key":"R3-20250618","first-page":"1439","article-title":"Serotonin syndrome: a brief review.","volume":"168","author":"Birmes","year":"2003","journal-title":"CMAJ"},{"key":"R4-20250618","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0736-4679(98)00057-2","article-title":"Treatment of the serotonin syndrome with cyproheptadine.","volume":"16","author":"Graudins","year":"1998","journal-title":"J Emerg Med"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00005792-200007000-00001","article-title":"Serotonin syndrome presentation of 2 cases and review of the literature.","volume":"79","author":"Peter","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"R6-20250618","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0749-0704(05)70368-7","article-title":"Serotonin syndrome. A clinical update.","volume":"13","author":"Mills","year":"1997","journal-title":"Crit Care Clin"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/JCP.0000000000001159","article-title":"Use of cyproheptadine for the treatment of serotonin syndrome: a case series.","volume":"40","author":"Frye","year":"2020","journal-title":"J Clin Psychopharmacol"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40560-020-00474-z","article-title":"The use of automated pupillometry to assess cerebral autoregulation: a retrospective study.","volume":"8","author":"Cornejo","year":"2020","journal-title":"J Intensive Care"},{"key":"R12-20250618","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/0885066619881124","article-title":"Quantitative Pupillometry in the intensive care unit.","volume":"36","author":"Bower","year":"2021","journal-title":"J Intensive Care Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037852","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T16:00:53Z","timestamp":1750262453000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":9,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037852","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,4,12]]}}}